Xiaoyan Cui
About
In The Last Decade
Xiaoyan Cui
42 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 137
- Molecular Biology 313
- Oncology 265
- Pulmonary and Respiratory Medicine 171
- Cancer Research 168
- Pharmacology 127
Countries citing papers authored by Xiaoyan Cui
This map shows the geographic impact of Xiaoyan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Cui more than expected).
Fields of papers citing papers by Xiaoyan Cui
This network shows the impact of papers produced by Xiaoyan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Cui. The network helps show where Xiaoyan Cui may publish in the future.
Co-authorship network of co-authors of Xiaoyan Cui
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Cui. A scholar is included among the top collaborators of Xiaoyan Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Cui. Xiaoyan Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 8 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 48 | |
| 8 | 4 | |
| 9 | Carcinoma In Situ Involving Sclerosing Adenosis: Seeking the Salient Histological Characteristics to Prevent Overdiagnosis. | 3 |
| 10 | 40 | |
| 11 | 23 | |
| 12 | 3 | |
| 13 | Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer. | 15 |
| 14 | Traditional Chinese medicine and related active compounds against hepatitis B virus infection. | 105 |
| 15 | 6 | |
| 16 | 10 | |
| 17 | 246 | |
| 18 | 56 | |
| 19 | Analysis of cluster system based on Linux | 1 |
| 20 | 74 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.